Oslo, Norway, May 31, 2012: Photocure ASA (OSE: PHO), is pleased to announce the results of its Phase 2b study for Visonac, a novel topical treatment under development for moderate to severe acne. Photocure will host a presentation and webcast at 15.00 CET / 14.00 BST / 09.00 EST to present the results on Thursday 31st May 2012.
WHERE: Hotel Continental, Stortingsgaten 24/26, Oslo, Norway
- Kjetil Hestdal, President & CEO, Photocure
- Dr. David Pariser, MD, Principal Investigator
- Grete Hogstad, Vice President Strategic Marketing, Photocure
- Inger Ferner Heglund, VP Research & Development, Photocure
You can access the webcast and presentation via this link: http://webtv.hegnar.no/webcast.php?id=65542.